Bloomberg Law
Dec. 2, 2022, 9:35 PM

U.S. Renal Care’s Loan Drops Following Third Quarter Earnings

Eliza Ronalds-Hannon
Eliza Ronalds-Hannon
Bloomberg News
Rachel Butt
Rachel Butt
Bloomberg News

U.S. Renal Care’s $1.6 billion term loan hit a new low after the company’s latest earnings report showed declining margins, according to people with knowledge of the results.

The dialysis provider’s first-lien term loan due in 2026 was quoted as low as 56.5 cents on the dollar on Friday, according to data compiled by Bloomberg. That’s down from about 61.4 cents before the earnings were released in late November.

The financial results showed adjusted earnings of $234 million and a decline in gross margin of 400 basis points, the people said, even as revenue increased, climbing 2.4% compared ...